Jan 24, 2025
Familial hypercholesterolemia, cardiac arrest therapy, Factor XI
inhibition, and tricuspid valve interventions are the topics John
Mandroa, MD, discusses in this week’s podcast.
This podcast is intended for healthcare professionals
only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. Familial hypercholesterolemia
- Danish Registry Study:
https://doi.org/10.1093/eurheartj/ehae912
II. Cardiac Arrest
- Vallentin and Colleagues RCT
https://www.nejm.org/doi/full/10.1056/NEJMoa2407616
III. Factor XI
- AZALEA
https://www.nejm.org/doi/full/10.1056/NEJMoa2406674
- OCEANIC
https://www.nejm.org/doi/full/10.1056/NEJMoa2407105
- VTE Study of Abelacimab 2021
https://www.nejm.org/doi/10.1056/NEJMoa2105872
IV. Tricuspid Valve Interventions
- TRILUMINATE 1-year Study
https://doi.org/10.1016/j.jacc.2024.10.086
- Stone Editorial
https://doi.org/10.1016/j.jacc.2024.11.045
- TRISCEND Main Paper
https://www.nejm.org/doi/full/10.1056/NEJMoa2401918
- QOL Paper
https://doi.org/10.1016/j.jacc.2024.10.067
- PASTE Registry
https://doi.org/10.1016/j.jacc.2024.10.068
- AL-Lamee Editorial
https://doi.org/10.1016/j.jacc.2024.10.085
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean
of Weill Cornell Medicine, Robert A. Harrington, MD.
https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net